// App-Quantinova.ai

1300 : BACH2 Is Required for Pre-B Cell Receptor Checkpoint Control and p53-Dependent Tumor Surveillance

Researchers

Presenter

  • Huining Kang

Principal Investigators

  • Richard C. Harvey

  • Ari Melnick

  • Markus Muschen

  • Chuanxin Huang

  • Maike Buchner

  • Zhengshan Chen

  • Huimin Geng

  • Andrew Hall

  • Kazuhiko Igarashi

  • William L. Carroll

  • Cheryl L. Willman

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

Locations

  • United Kingdom

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved